BGC > Product Search > Relugolix

EINECS :237-099-7
Molecular formula :C29H27F2N7O5S

EINECS :237-099-7
Molecular formula :C29H27F2N7O5S

EINECS :237-099-7
Molecular formula :C29H27F2N7O5S

Description :
Relugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH) receptor antagonist administered orally. By preventing LH-RH from binding with the LH-RH receptor in the anterior pituitary gland and suppressing the secretion of luteinizing hormone (LH) and follicle stimulation hormone (FSH) from the anterior pituitary gland, TAK-385 controls the effect of LH and FSH on the ovary, reduces the level of estrogen in blood, which is known to be associated with the development of endometriosis and uterine fibroids, and is expected to improve the symptoms of these disorders.

• Molecular Weight :623.63
• Melting Point :228°C (dec.)
• Purity :≥95%

Molecular Formula :
C29H27F2N7O5S
Canonical SMILES :
CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC
InChI :
InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)
InChIKey :
AOMXMOCNKJTRQP-UHFFFAOYSA-N
Solubility :
Soluble in DMF, DMSO, Ethanol, Ethyl acetate, Tetrahydrofuran
Appearance :
Crystalline Solid
Application :
Androgen Antagonists
Storage : Store at -20°C
Synonyms :
TAK-385; N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea; Orgovyx; RVT 601; 1-{4-[1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea

More details are to be found here